Lytix Biopharma ASA (OSL:LYTIX)
Norway · Delayed Price · Currency is NOK 8.42
-0.08 (-0.94%)
Aug 4, 2026, 12:26 PM CET
Lytix Biopharma ASA Market Cap
Lytix Biopharma ASA has a market cap or net worth of 647.5 million as of August 4, 2026. Its market cap has increased by 6.58% in one year.
Market Cap
647.50M
Enterprise Value
529.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.42
ChartMarket Cap Chart
Since June 14, 2021, Lytix Biopharma ASA's market cap has decreased from 720.55M to 647.50M, a decrease of -10.14%. That is a compound annual growth rate of -2.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 647.50M | -3.99% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
| Jun 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Thor Medical ASA | 2.08B |
| Circio Holding ASA | 1.95B |
| Nykode Therapeutics AS | 1.10B |
| ArcticZymes Technologies ASA | 1.00B |
| Zelluna ASA | 682.40M |
| Oncoinvent ASA | 367.23M |
| SoftOx Solutions AS | 236.24M |
| Aqua Bio Technology ASA | 74.18M |